GBA
CELG

Garrison Bradford & Associates’s Celgene Corp CELG Stock Holding History

Garrison Bradford & Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-59,050
Closed -$3.79M – 87
2018
Q4 		$3.79M Sell
59,050
-4,700
-7% -$347K 3.42% 6
2018
Q3 		$5.71M Sell
63,750
-700
-1% -$61.9K 4.6% 4
2018
Q2 		$5.12M Sell
64,450
-1,300
-2% -$108K 4.2% 5
2018
Q1 		$5.87M Sell
65,750
-4,450
-6% -$427K 4.99% 5
2017
Q4 		$7.33M Sell
70,200
-1,170
-2% -$132K 6.06% 4
2017
Q3 		$10.4M Sell
71,370
-600
-0.8% -$81.7K 8.71% 3
2017
Q2 		$9.35M Sell
71,970
-100
-0.1% -$12.3K 8.09% 3
2017
Q1 		$8.97M Hold
72,070
– – 7.92% 3
2016
Q4 		$8.34M Buy
72,070
+400
+0.6% +$44.5K 7.69% 3
2016
Q3 		$7.49M Sell
71,670
-1,600
-2% -$173K 7.05% 3
2016
Q2 		$7.23M Sell
73,270
-400
-0.5% -$41.4K 7.08% 3
2016
Q1 		$7.37M Buy
73,670
+6,070
+9% +$625K 8.58% 2
2015
Q4 		$8.1M Sell
67,600
-400
-0.6% -$46.3K 9.07% 2
2015
Q3 		$7.36M Sell
68,000
-200
-0.3% -$24.8K 8.12% 2
2015
Q2 		$7.89M Sell
68,200
-500
-0.7% -$57.2K 7.71% 2
2015
Q1 		$7.92M Buy
68,700
+900
+1% +$108K 7.4% 2
2014
Q4 		$7.58M Buy
67,800
+2,550
+4% +$269K 6.87% 2
2014
Q3 		$6.18M Sell
65,250
-550
-0.8% -$49.6K 6.18% 2
2014
Q2 		$5.65M Sell
65,800
-3,600
-5% -$274K 5.26% 3
2014
Q1 		$4.84M Buy
69,400
+3,600
+5% +$285K 4.67% 4
2013
Q4 		$5.56M Buy
65,800
+200
+0.3% +$15.8K 5.25% 2
2013
Q3 		$5.06M Sell
65,600
-1,000
-2% -$70.1K 5.17% 3
2013
Q2 		$3.9M Buy
+66,600
New +$4.01M 4.19% 5

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Garrison Bradford & Associates's CELG Position: Q1 2019 in Review

Garrison Bradford & Associates sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 59,050 shares — an estimated $3.79M sold.

Garrison Bradford & Associates first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $10.4M in Q3 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Garrison Bradford & Associates reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Garrison Bradford & Associates sold 59,050 Celgene Corp shares in Q1 2019, an estimated $3.79M.
  • Garrison Bradford & Associates first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
  • Garrison Bradford & Associates's Celgene Corp position peaked at $10.4M in Q3 2017.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Garrison Bradford & Associates's 13F filing for Q1 2019, filed 1 May 2019.